Skip to main content
NBIX
NASDAQ Life Sciences

FDA Clears Phase 2 Trial for Neurocrine's Alzheimer's Drug NBI-1117567

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$153.37
Mkt Cap
$15.59B
52W Low
$122.138
52W High
$186.12
52W Position info
26% above low
Off High info
18% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

NBIX sits 26% above its 52-week low of $122.138.

Summary

The FDA accepted Neurocrine's IND for NBI-1117567, allowing a Phase 2 study in Alzheimer's cognition. This is the third muscarinic agonist from the Nxera collaboration to reach Phase 2, following direclidine (Phase 3) and NBI-1117570 (Phase 2). Nxera receives a $10 million milestone payment, recognized as revenue in Q3 FY2026. The milestone is modest relative to Neurocrine's $15.6B market cap, but the pipeline advancement validates the muscarinic platform and adds a new clinical asset in a high-unmet-need indication. Neurocrine's Q2 beat and raised guidance already reflect strong commercial momentum; this news reinforces the long-term pipeline story.

At the time of this announcement, NBIX was trading at $153.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.6B. The 52-week trading range was $122.14 to $186.12. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NBIX - Latest Insights

NBIX
Nov 03, 2026, 2:36 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $168.29
Real-time Price: $167.40 info
Change: -$0.890 (-0.53%) info
Market Cap: $16.944B info
NBIX
Nov 02, 2026, 4:50 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $157.48
Real-time Price: $167.40 info
Change: +$9.92 (+6%) info
Market Cap: $16.944B info
NBIX
Nov 02, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $146.96
Real-time Price: $167.40 info
Change: +$20.44 (+14%) info
Market Cap: $16.944B info
NBIX
Nov 02, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $145.35
Real-time Price: $167.40 info
Change: +$22.05 (+15%) info
Market Cap: $16.944B info
NBIX
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $167.40
Real-time Price: $167.40 info
Change: $0 (0%) info
Market Cap: $16.944B info